On Wednesday, the European Commission will approve a contract to buy up to 160 million doses of a Covid-19 vaccine produced by Moderna, President Ursula von der Leyen announced on Tuesday.
According to the results of the clinical trials, the Moderna vaccine could be almost 95% effective against Covid-19.
All vaccines will be evaluated by the European Medicine Agency, and will only be authorised and placed on the market if they are safe and effective, according to von der Leyen.
"Transparency is crucial and of the utmost importance," she said. "Once the vaccine is indeed proven as safe and effective, every Member State will receive it at the same time, on a pro-rata basis, at the same conditions."
Related News
- Belgium subscribes to purchase of Pfizer's coronavirus vaccine
- European Commission purchases 300 million doses of Pfizer's Covid-19 vaccine
The contract with Moderna will be the sixth contract for a Covid-19 vaccine that the EU approves, and the Commission is working on a seventh one as well.
Tomorrow we will approve a 6th contract for up to 160 million doses of the @moderna_tx vaccine.
We're building one of the most comprehensive #COVID19 vaccine portfolios in the?Safe & effective vaccines can help us end the pandemic. https://t.co/ymfqmMLWIJ — Ursula von der Leyen (@vonderleyen) November 24, 2020
"The EU is working on one of the most comprehensive vaccine portfolios in the world," von der Leyen said. "This provides Europeans access to the most promising future vaccines under development so far."
Maïthé Chini
The Brussels Times
